OP-3136

· Olema Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OP-3136, covering 2025-10-10 to 2025-10-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors [Phase 1]